Betticher DC - Search Results

1

Ex vivo assessment of chemotherapy-induced apoptosis and associated molecular changes in patient tumor samples.

Pirnia F, Frese S, Gloor B, Hotz MA, Luethi A, Gugger M, Betticher DC, Borner MM. Pirnia F, et al. Among authors: betticher dc. Anticancer Res. 2006 May-Jun;26(3A):1765-72. Anticancer Res. 2006. PMID: 16827105 Free article.

2

[Progress in surgical therapy of bronchus carcinoma].

Ris HB, Eigenmann V, Signer C, Betticher DC, Gugger M, von Briel C. Ris HB, et al. Among authors: betticher dc. Ther Umsch. 1998 Jul;55(7):394-8. Ther Umsch. 1998. PMID: 9702101 German.

3

[Is preoperative chemotherapy in locally advanced non-small-cell bronchial carcinoma of value?].

Betticher DC, von Briel C, Gugger M, Cerny T, Ris HB. Betticher DC, et al. Ther Umsch. 1998 Jul;55(7):399-401. Ther Umsch. 1998. PMID: 9702102 Review. German.

4

Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.

Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC. Vonlanthen S, et al. Among authors: betticher dc. Oncogene. 1998 Nov 26;17(21):2779-85. doi: 10.1038/sj.onc.1202501. Oncogene. 1998. PMID: 9840942

5

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.

Borner MM, Brousset P, Pfanner-Meyer B, Bacchi M, Vonlanthen S, Hotz MA, Altermatt HJ, Schlaifer D, Reed JC, Betticher DC. Borner MM, et al. Among authors: betticher dc. Br J Cancer. 1999 Feb;79(5-6):952-8. doi: 10.1038/sj.bjc.6690152. Br J Cancer. 1999. PMID: 10070896 Free PMC article.

6

p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer.

Vonlanthen S, Heighway J, Kappeler A, Altermatt HJ, Borner MM, Betticher DC. Vonlanthen S, et al. Among authors: betticher dc. Int J Oncol. 2000 May;16(5):951-7. doi: 10.3892/ijo.16.5.951. Int J Oncol. 2000. PMID: 10762631

7

Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors.

Lardinois D, Rechsteiner R, Läng RH, Gugger M, Betticher D, von Briel C, Krueger T, Ris HB. Lardinois D, et al. Ann Thorac Surg. 2000 May;69(5):1550-5. doi: 10.1016/s0003-4975(00)01140-1. Ann Thorac Surg. 2000. PMID: 10881840

8

Uncertain identity of doxorubicin-resistant MCF-7 cell lines expressing mutated p53.

Pirnia F, Breuleux M, Schneider E, Hochmeister M, Bates SE, Marti A, Hotz MA, Betticher DC, Borner MM. Pirnia F, et al. Among authors: betticher dc. J Natl Cancer Inst. 2000 Sep 20;92(18):1535-6. doi: 10.1093/jnci/92.18.1535. J Natl Cancer Inst. 2000. PMID: 10995814 Free article. No abstract available.

9

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression.

Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM, van Lohuizen M, Betticher DC. Vonlanthen S, et al. Among authors: betticher dc. Br J Cancer. 2001 May 18;84(10):1372-6. doi: 10.1054/bjoc.2001.1791. Br J Cancer. 2001. PMID: 11355949 Free PMC article.

10

Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.

Gugger M, Kappeler A, Vonlanthen S, Altermatt HJ, Ris HB, Lardinois D, Borner MM, Heighway J, Betticher DC. Gugger M, et al. Among authors: betticher dc. Lung Cancer. 2001 Aug-Sep;33(2-3):229-39. doi: 10.1016/s0169-5002(01)00196-9. Lung Cancer. 2001. PMID: 11551418

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters